AzTrials
AzTrials

Osgood Schlatter DiseaseNCT02799394

Effect of Activity Modification and Exercises in Young Adolescents With Osgood Schlatter Disease.

A study testing Activity modification, exercises and gradual return to sport in people with Osgood Schlatter Disease, run by Aalborg University at 2 sites in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to investigate the effect of activity modification, exercises and a gradual return to sport in adolescents (age 10-14) with Osgood Schlatter disease. The primary outcome is self-reported recovery on a 7-point Likert scale at 3 months. Read more about this study

Who is it for?
Ages 10 to 14 years
Conditions the study is for
Osgood Schlatter Disease
What is being tested?
Activity modification, exercises and gradual return to sport
Could I receive a placebo?
No, everyone receives an active treatment
How many people
51 participants
Where
2 sitesDenmark
Study dates
Jun 2016to Dec 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 to 14 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • 10-14 years of age
  • Pain at tuberositas patellae during two or more of the following activities: Sitting with a bent knee, squatting, running, jumping or stair ambulation
  • Pain during palpation of tuberositas patellae
  • Knee pain for 6 weeks or more

Who cannot join

  • Other knee conditions that may manifest as anterior knee pain (Patellofemoral pain, iliotibial band syndrome, sinding-larson-johanson disease).
  • Previous surgery
  • Pain from the hip or back that interferes with activities of daily living.
  • Habitual patella luxations
  • Clinical suspicion of meniscal lesion

Trial locations and contacts

2 sites in 1 country.

Denmark2 sites
  • Aalborg Universitetshospital

    Aalborg, The North Denmark Region, 9000

  • Hvidovre-Amager Hospital

    Hvidovre, 2650

Other trials in Denmark

About this study

The purpose of this study is to investigate the effect of activity modification, exercises and a gradual return to sport in adolescents (age 10-14) with Osgood Schlatter disease. The primary outcome is self-reported recovery on a 7-point Likert scale at 3 months. Secondary endpoints include 4 and 8 weeks and 6 and 12 months after inclusion into the project. The adolescents will be recruited from primary schools, general practitioners and through online advertising on Facebook.

Being tested
Activity modification, exercises and gradual return to sport
Medical subject headings
Osteochondrosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Activity modification, exercises and gradual return to sportOther

Study groups in NCT02799394
Study groupRoleWhat they receive
Activity modification, exercises and gradual return to sportExperimentalNot described
Receives: Other: Activity modification, exercises and gradual return to sport

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self-reported recovery on a 7-point Likert scale

    Measured: 3 months

Secondary outcomes (8)
  1. Self-reported recovery on a 7-point Likert scale

    Measured: 4 and 8 weeks + 6 and 12 months after inclusion.

  2. Self-report questionnaire "Knee Injury and Osteoarthritis Outcome Score"

    Measured: 4, 8 and 12 weeks + 6 and 12 months after inclusion.

  3. Isometric hip and knee extension strength assessed using a strap-mounted dynamometer

    Measured: 4, 8 and 12 weeks after inclusion.

  4. Pressure pain thresholds at tuberositas patella, center of patella and lateral elbow assessed by a hand held pressure algometer.

    Measured: 4, 8 and 12 weeks after inclusion.

  5. Thigh circumference measured using tape measure.

    Measured: 4, 8 and 12 weeks after inclusion.

  6. Vertical jump for height [calculated as the difference between reach height and maximal jump height. This will be measured using a ruler]

    Measured: 4, 8 and 12 weeks after inclusion.

  7. Single leg jump for distance (defined as the maximal length the subject can jump on one leg. Measured using a ruler).

    Measured: 4, 8 and 12 weeks after inclusion.

  8. Flexibility of the hamstrings and quadriceps [measured using goniometer].

    Measured: 4, 8 and 12 weeks after inclusion.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jun 2016 (estimated)
  2. Study startJun 2016
  3. Primary completionDec 2017
  4. Study completionDec 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
51 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02799394
Sponsor's protocol ID
N- 20140100-1
Status last verified
Jan 2018
First submitted
10 Jun 2016
Last updated
30 Jan 2018
Results posted
No
Data monitoring committee
No
Individual data sharing
Yes: Data will be made publicly available no later than six months after the final publication.

Publications

  • Rathleff MS, Winiarski L, Krommes K, Graven-Nielsen T, Holmich P, Olesen JL, Holden S, Thorborg K. Activity Modification and Knee Strengthening for Osgood-Schlatter Disease: A Prospective Cohort Study. Orthop J Sports Med. 2020 Apr 6;8(4):2325967120911106. doi: 10.1177/2325967120911106. eCollection 2020 Apr.

    PubMed 32284945

Questions about this trial

What is this clinical trial studying?

A study testing Activity modification, exercises and gradual return to sport in people with Osgood Schlatter Disease, run by Aalborg University at 2 sites in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Jan 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Self-reported recovery on a 7-point Likert scale (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02799394, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jan 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in